Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
81.78
-1.68 (-2.01%)
Apr 28, 2026, 1:14 PM EDT - Market open
Edwards Lifesciences Revenue
Edwards Lifesciences had revenue of $1.65B in the quarter ending March 31, 2026, with 16.70% growth. This brings the company's revenue in the last twelve months to $6.30B, up 14.15% year-over-year. In the year 2025, Edwards Lifesciences had annual revenue of $6.07B with 11.55% growth.
Revenue (ttm)
$6.30B
Revenue Growth
+14.15%
P/S Ratio
7.46
Revenue / Employee
$393,969
Employees
16,000
Market Cap
47.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.07B | 628.10M | 11.55% |
| Dec 31, 2024 | 5.44B | 429.50M | 8.57% |
| Dec 31, 2023 | 5.01B | 546.00M | 12.23% |
| Dec 31, 2022 | 4.46B | -768.50M | -14.69% |
| Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
| Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
| Dec 31, 2019 | 4.35B | 625.20M | 16.79% |
| Dec 31, 2018 | 3.72B | 287.50M | 8.37% |
| Dec 31, 2017 | 3.44B | 471.60M | 15.91% |
| Dec 31, 2016 | 2.96B | 470.00M | 18.85% |
| Dec 31, 2015 | 2.49B | 170.80M | 7.35% |
| Dec 31, 2014 | 2.32B | 277.40M | 13.56% |
| Dec 31, 2013 | 2.05B | 145.90M | 7.68% |
| Dec 31, 2012 | 1.90B | 221.00M | 13.17% |
| Dec 31, 2011 | 1.68B | 231.60M | 16.01% |
| Dec 31, 2010 | 1.45B | 125.60M | 9.51% |
| Dec 31, 2009 | 1.32B | 83.70M | 6.76% |
| Dec 31, 2008 | 1.24B | 146.60M | 13.44% |
| Dec 31, 2007 | 1.09B | 54.10M | 5.22% |
| Dec 31, 2006 | 1.04B | 39.10M | 3.92% |
| Dec 31, 2005 | 997.90M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 45.13B |
| Medtronic | 35.48B |
| Stryker | 25.12B |
| Koninklijke Philips | 20.94B |
| GE HealthCare Technologies | 20.63B |
| Boston Scientific | 20.61B |
| Zimmer Biomet Holdings | 8.23B |
| Smith & Nephew | 6.16B |
EW News
- 6 hours ago - Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference - Business Wire
- 4 days ago - Edwards Lifesciences Stock Surges On Heart Valve Devices Growth - Benzinga
- 4 days ago - Edwards Lifesciences beats quarterly estimates on robust demand for artificial heart valves - Reuters
- 4 days ago - Edwards Lifesciences Earnings Call Transcript: Q1 2026 - Transcripts
- 4 days ago - Edwards Lifesciences Reports First Quarter Results - Business Wire
- 12 days ago - Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026 - Business Wire
- 4 weeks ago - Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits - Business Wire
- 6 weeks ago - Edwards Lifesciences Transcript: Leerink Global Healthcare Conference 2026 - Transcripts